Stephen Wasserman

Background

About Stephen Wasserman

STEPHEN E. WASSERMAN Board member and senior executive experienced in leading organizations to outperform expectations for revenue, profits and operating goals for growth and turnarounds. Probes to reveal unseen opportunities, ways to reduce risk and increase success of new initiatives. Injects energy and commitment to static businesses. Acquires top talent and builds cohesive management teams. P&L responsibility of $20 million to $200+ million with Olympus, Datascope, Bayer, Revlon. Chairman of the board of Cryoport Inc.(CYRX). WASSERMAN & ASSOCIATES, Managing Director, White Plains, New York, 2006-Present. Serve as effective board member specializing in Compensation and Audit committees. Led the creation of a performance based compensation program resulting in major goal achievements. Provide consulting services focused on profit improvement, organization structure, business development strategy and interim senior management. OLYMPUS AMERICA, INC, Melville, New York, 1997-2006 Member, Executive Committee, America Operations Member, Global Management Committee (GMC), In Vitro Diagnostics Group Vice President, Diagnostic Systems Products Hired to accelerate revenue and turn around business unit. Within two years, Olympus became the fastest growing company in the global IVD market with global sales increasing from $180 million to $475 million. Broadened product lines and restructured sales organization driving U.S. sales 12% per year (4X industry average). Created vision to attract top team leading to sustained growth, profitability and productivity improvements. Reached breakeven two years earlier than plan and achieved operating income greater than 10%. DATASCOPE CORP,(NASDAQ) Montvale, New Jersey, 1994-1997 Chief Financial Officer and Treasurer, Datascope Corporation, 1994-1997 President, Patient Monitoring Division, 1994-1996.